ATARA BIOTHERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -16.20% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-16
- ATARA BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -16.20%.
- ATARA BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was -4.50%.
- ATARA BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -3.80%.
- ATARA BIOTHERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2021 was -2.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 4 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | -16.20% 10-K · filed 2026-03-16 | ||
| 2023-12-31 | -4.50% 10-K · filed 2025-03-07 | ||
| 2022-12-31 | -3.80% 10-K · filed 2024-03-28 | ||
| 2021-12-31 | -2.00% 10-K · filed 2023-02-08 | ||
| 2020-12-31 | -2.40% 10-K · filed 2023-02-08 | ||
| 2019-12-31 | 0.10% 10-K · filed 2022-02-28 | ||
| 2018-12-31 | 0.00% 10-K · filed 2021-03-01 | ||
| 2017-12-31 | -1.50% 10-K · filed 2020-02-27 | ||
| 2016-12-31 | -1.30% 10-K · filed 2019-02-26 | ||
| 2015-12-31 | -0.60% 10-K · filed 2018-02-27 | 0.60% 10-K · filed 2016-03-04 | |
| 2014-12-31 | -7.30% 10-K · filed 2017-03-09 | ||
| 2013-12-31 | 6.80% 10-K · filed 2016-03-04 | -6.80% 10-K · filed 2015-02-26 | |
| 2012-12-31 | -1.40% 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |